Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126235352 | 12623535 | 2 | F | 20160803 | 20160804 | 20160811 | EXP | US-BAUSCH-BL-2016-018676 | BAUSCH AND LOMB | HAROON N, RAZA M, BHAT Y. HYPOMAGNESEMIA AND CHEMOTHERAPY, DIAGNOSTIC DILEMMA, AND TREATMENT CHALLENGE: CASE REPORT AND LITERATURE REVIEW. AMERICAN JOURNAL OF THERAPEUTICS. 2016 AUG 01;23(4):E1085-E1090. | 63.00 | YR | F | Y | 0.00000 | 20160811 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126235352 | 12623535 | 1 | PS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | N | 20985 | ||||||||||
| 126235352 | 12623535 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | N | 20985 | ||||||||||
| 126235352 | 12623535 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | N | 20985 | ||||||||||
| 126235352 | 12623535 | 4 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 21748 | ||||||||||
| 126235352 | 12623535 | 5 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 6 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 7 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 8 | SS | FOLINIC ACID | LEUCOVORIN | 1 | N | 0 | |||||||||||
| 126235352 | 12623535 | 9 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 10 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 11 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 12 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | ONCE IN 2 WEEKS | N | 0 | QOW | ||||||||
| 126235352 | 12623535 | 13 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | ONCE IN 3 WEEKS | N | 0 | Q3W | ||||||||
| 126235352 | 12623535 | 14 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 126235352 | 12623535 | 15 | SS | XELODA | CAPECITABINE | 1 | Unknown | U | 0 | ||||||||||
| 126235352 | 12623535 | 16 | SS | XELODA | CAPECITABINE | 1 | U | 0 | |||||||||||
| 126235352 | 12623535 | 17 | SS | AVASTIN | BEVACIZUMAB | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 18 | SS | AVASTIN | BEVACIZUMAB | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 19 | SS | AVASTIN | BEVACIZUMAB | 1 | Unknown | N | 0 | ||||||||||
| 126235352 | 12623535 | 20 | SS | AVASTIN | BEVACIZUMAB | 1 | N | 0 | |||||||||||
| 126235352 | 12623535 | 21 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 22 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 23 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 24 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 25 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 26 | C | CELECOXIB. | CELECOXIB | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 27 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 28 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 29 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 30 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 31 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 32 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126235352 | 12623535 | 33 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126235352 | 12623535 | 1 | Retroperitoneal cancer |
| 126235352 | 12623535 | 2 | Metastases to peritoneum |
| 126235352 | 12623535 | 3 | Colon cancer metastatic |
| 126235352 | 12623535 | 4 | Product used for unknown indication |
| 126235352 | 12623535 | 5 | Adenocarcinoma of appendix |
| 126235352 | 12623535 | 6 | Retroperitoneal cancer |
| 126235352 | 12623535 | 7 | Metastases to peritoneum |
| 126235352 | 12623535 | 8 | Colon cancer metastatic |
| 126235352 | 12623535 | 9 | Adenocarcinoma of appendix |
| 126235352 | 12623535 | 10 | Retroperitoneal cancer |
| 126235352 | 12623535 | 11 | Metastases to peritoneum |
| 126235352 | 12623535 | 12 | Colon cancer metastatic |
| 126235352 | 12623535 | 14 | Product used for unknown indication |
| 126235352 | 12623535 | 15 | Retroperitoneal cancer |
| 126235352 | 12623535 | 16 | Colon cancer metastatic |
| 126235352 | 12623535 | 17 | Adenocarcinoma of appendix |
| 126235352 | 12623535 | 18 | Retroperitoneal cancer |
| 126235352 | 12623535 | 19 | Metastases to peritoneum |
| 126235352 | 12623535 | 20 | Colon cancer metastatic |
| 126235352 | 12623535 | 21 | Product used for unknown indication |
| 126235352 | 12623535 | 22 | Product used for unknown indication |
| 126235352 | 12623535 | 23 | Product used for unknown indication |
| 126235352 | 12623535 | 24 | Product used for unknown indication |
| 126235352 | 12623535 | 25 | Product used for unknown indication |
| 126235352 | 12623535 | 26 | Product used for unknown indication |
| 126235352 | 12623535 | 27 | Product used for unknown indication |
| 126235352 | 12623535 | 28 | Product used for unknown indication |
| 126235352 | 12623535 | 29 | Product used for unknown indication |
| 126235352 | 12623535 | 30 | Product used for unknown indication |
| 126235352 | 12623535 | 31 | Product used for unknown indication |
| 126235352 | 12623535 | 32 | Product used for unknown indication |
| 126235352 | 12623535 | 33 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126235352 | 12623535 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126235352 | 12623535 | Diarrhoea | |
| 126235352 | 12623535 | Hypomagnesaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126235352 | 12623535 | 1 | 2007 | 201005 | 0 | |
| 126235352 | 12623535 | 2 | 201005 | 0 | ||
| 126235352 | 12623535 | 3 | 201105 | 0 | ||
| 126235352 | 12623535 | 5 | 2007 | 0 | ||
| 126235352 | 12623535 | 6 | 201005 | 0 | ||
| 126235352 | 12623535 | 7 | 201105 | 0 | ||
| 126235352 | 12623535 | 9 | 2007 | 0 | ||
| 126235352 | 12623535 | 10 | 201005 | 0 | ||
| 126235352 | 12623535 | 11 | 201105 | 0 | ||
| 126235352 | 12623535 | 17 | 2007 | 0 | ||
| 126235352 | 12623535 | 18 | 201005 | 0 | ||
| 126235352 | 12623535 | 19 | 201210 | 0 |